Welcome to our dedicated page for iShares USD Systematic Bond ETF SEC filings (Ticker: USBF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on iShares USD Systematic Bond ETF's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into iShares USD Systematic Bond ETF's regulatory disclosures and financial reporting.
iShares USD Systematic Bond ETF (Series of iShares Trust) filed its monthly Form NPORT-P covering the period ended 30 Apr 2025. The fund reported total assets of $3.10 billion, liabilities of $0.29 billion, and net assets of $2.80 billion. No bank or affiliate borrowings were outstanding, and payables for when-issued purchases totaled just $6.5 million.
Risk metrics show moderate exposure concentrated in short- to intermediate-term maturities: DV01 of $2,936 (3-m) and $960 k (1-yr) and a 5-yr DV100 of $67.6 million. All credit-spread sensitivity is investment-grade; the filing lists zero non-investment-grade exposure.
The fund recorded three consecutive positive monthly returns of 1.11%, 0.43% and 0.78%. Securities-lending activity is diversified across 15 counterparties, with the largest loan exposure to JP Morgan Securities (≈$56.8 million). No non-cash collateral was reported. Overall, the filing indicates a low-leverage, investment-grade portfolio with steady recent performance.
iShares CMBS ETF (Series ID S000035914) – Form N-PORT-P, reporting period 30 Apr 2025
The filing shows total assets of $431.66 million against liabilities of only $0.41 million, resulting in net assets of $431.25 million. No borrowings, preferred stock or controlled-foreign-corporation positions were reported, indicating a clean capital structure. Payables for when-issued or delayed-delivery purchases were limited to $309.7 k.
Portfolio risk: All exposures are in U.S. dollars. DV01 totals demonstrate moderate interest-rate sensitivity, with the largest exposure at the 5-year point (DV01 = $145.3 k; DV100 = $14.53 million). Credit-spread risk is entirely investment-grade; the 5-year CS01 is $149.99 k, while non-investment-grade exposure is zero, suggesting a high-quality portfolio.
Performance: The fund delivered positive total returns in each of the last three months: 1.56 %, 0.24 % and 0.89 %. Realized gains were negative in all three months (-$126 k to -$279 k), but were more than offset by sizable unrealized appreciation in Months 1 and 3 (up to $5.70 million), indicating market price gains on existing positions.
Flows and securities-lending details were not disclosed beyond confirmation that at least one counterparty provided only cash collateral. No derivative detail was supplied for Item B.5(c).
Key takeaways for investors: The ETF remains well-capitalized, uses no leverage, and is concentrated in investment-grade commercial mortgage-backed securities, producing steady if modest monthly gains. Interest-rate and credit-spread sensitivities appear manageable given the fund’s size, and recent unrealized gains highlight supportive market conditions for CMBS spreads.
iShares Trust – iShares iBonds Oct 2034 Term TIPS ETF filed its monthly Form N-PORT for the period ended 30 April 2025. The Series reports total assets of $40.92 million against total liabilities of $3.29 thousand, resulting in net assets of $40.92 million. No borrowings, preferred shares or payables on firm-commitment purchases were outstanding.
Risk metrics: Interest-rate DV01 exposure in U.S. dollars totals $18.14 (3-month), $217.01 (1-year), $12.72 thousand (5-year) and $21.21 thousand (10-year); the 30-year bucket shows no exposure. Corresponding DV100 figures scale proportionally, with the 10-year bucket at $2.12 million. The Fund reports zero credit-spread risk, consistent with its mandate to hold U.S. Treasury Inflation-Protected Securities (TIPS).
Performance: The Fund recorded monthly total returns of +2.77 %, +0.86 % and -0.22 % for the three months prior to the report date. Unrealized appreciation reached $916.7 k in Month 1, moderated to $38.5 k in Month 2, and swung to an unrealized loss of $316.6 k in Month 3; realized gains/losses were de-minimis over the period.
Liquidity & cash: Cash and cash equivalents not otherwise classified amount to $9.4 k. No controlled foreign corporations, derivatives exposures, or securities-lending non-cash collateral are reported. Flow data (sales and redemptions) were not provided in the excerpt.
The filing indicates the Fund’s fiscal year-end is 31 October 2025 and LEI is 529900HZHST35R3RRN63. No statement confirms that this is a final Form N-PORT filing.
iShares Trust – iShares 20+ Year Treasury Bond BuyWrite Strategy ETF (symbol: USBF) filed its Form NPORT-P covering the period ended 30 April 2025.
Fund size and balance sheet: Total assets were reported at $1.0656 billion with total liabilities of $25.1 million, leaving net assets of $1.0404 billion. Liabilities therefore represent roughly 2.4 % of assets, indicating a low leverage profile.
Performance (last three months):
- Month 1 (most recent): +3.71 %
- Month 2: +0.61 %
- Month 3: -0.77 %
The fund produced positive total returns in two of the last three months, although results show a modest reversal in Month 3.
Derivatives activity: The Series employs equity-index options as part of its buy-write strategy. For Month 1 the portfolio realised $5.9 million of option gains but booked $26.4 million of unrealised losses, signalling mark-to-market volatility. The pattern reversed in Month 2 with $6.5 million of realised losses offset by $27.0 million of unrealised gains. Month 3 again showed realised gains ($7.5 million) and a smaller unrealised loss ($1.2 million).
Non-derivative investments: Realised losses persisted across all three months (-$0.6 million, -$1.1 million, -$8.2 million respectively). Unrealised moves were highly positive in Month 1 (+$55.2 million) but negative in Months 2 and 3 (-$15.6 million and -$11.1 million).
Risk & leverage: The filing shows no outstanding borrowings, preferred stock, delayed-delivery payables or cash equivalents, suggesting a conservative capital structure. Credit-spread risk metrics were not populated, implying that the <1-year rolling average of debt exposure is below the 25 % NAV threshold.
Other observations: • Securities-lending collateral details were not provided. • The fund indicates this is not its final NPORT-P filing. • LEI codes are supplied for both the trust and the Series. • Sales/redemption flow data were not included in the excerpt.